Spss graduate pack 19.0 statistical software

Manufactured by IBM

Sourced in United States

SPSS Graduate Pack 19.0 is a statistical software package developed by IBM. It provides a comprehensive set of tools for data analysis, modeling, and reporting. The software is designed to assist students, researchers, and professionals in conducting quantitative research and making data-driven decisions. SPSS Graduate Pack 19.0 offers a wide range of statistical techniques, including regression analysis, hypothesis testing, and multivariate statistics.

Automatically generated - may contain errors

Lab products found in correlation

Close spelling variants of this product

SPSS Graduate Pack 19.0 SPSS 19.0 statistical software SPSS 19.0 statistical SPSS 19 statistical software 19.0 SPSS software SPSS Statistical 19.0 SPSS software pack SPSS 19.0 IBM SPSS software 19.0 SPSS statistical software

3 protocols using spss graduate pack 19.0 statistical software

Prognostic Significance of PKM2 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols

According to the cutoff value (the most significant split) [37 ], patients in our dataset were stratified into the PKM2-high group and the PKM2-low group. Student's t test and the Chi-square test were used to determine the significance of differences between the two groups. Overall survival curves were plotted according to the Kaplan–Meier method, and the log-rank test was applied for comparison. All differences were considered statistically significant at the level of P<0.05. Statistics were performed with SPSS Graduate Pack 19.0 statistical software (SPSS, Chicago, IL, USA) or GraphPad Prime 15.0.

Han B., Meng X., Chen H., Chen L., Liu X., Wang H., Liu D., Gao F., Lin L., Ming J., Sun B., Yin S., Wang R., Wu P., Cai J, & Jiang C. (2017). Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis. Aging (Albany NY), 9(8), 1885-1897.

+ Open protocol

+ Expand

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols

All statistical analyses were performed using SPSS Graduate Pack 19.0 statistical software (SPSS, Chicago, IL, USA). P-values of less than 0.05 were considered to be statistically significant. All data, including mean values, SE, and one-way ANOVA, were calculated and analysed with Prism GraphPad software.

Li J., Wang F., Wang G., Sun Y., Cai J., Liu X., Zhang J., Lu X., Li Y., Chen M., Chen L, & Jiang C. (2017). Combination epidermal growth factor receptor variant III peptide-pulsed dendritic cell vaccine with miR-326 results in enhanced killing on EGFRvIII-positive cells. Oncotarget, 8(16), 26256-26268.

+ Open protocol

+ Expand

Glioma Prognostic Biomarker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

The significance of differences between two groups was estimated with the Student t test and Chi-square test. Overall survival (OS) curves were plotted according to the Kaplan–Meier method, with the log-rank test applied for comparison. Pearson or Spearman correlationship analyses were used to confirm relationship between different genes. Cox regression was used to correlate Sufu expression with OS of high-grade glioma patients. All differences were considered statistically significant at the level of P < 0.05. Statistics were performed using the SPSS Graduate Pack 19.0 statistical software (SPSS, Chicago, IL, USA).

Liu X., Wang X., Du W., Chen L., Wang G., Cui Y., Liu Y., Dou Z., Wang H., Zhang P., Chang L., Yi L., Cai J, & Jiang C. (2014). Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis. Oncotarget, 5(22), 11681-11694.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!